As of 2024-12-13, the Relative Valuation of ExpreS2ion Biotech Holding AB (EXPRS2.ST) is (695.06) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 29.00 SEK, the upside of ExpreS2ion Biotech Holding AB based on Relative Valuation is -2496.7%.
The range of the Relative Valuation is (689.98) - (676.59) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.2x - 31.3x | 31.2x |
| Forward P/E multiples | 31.9x - 34.3x | 33.1x |
| Fair Price | (689.98) - (676.59) | (695.06) |
| Upside | -2479.2% - -2433.1% | -2496.7% |
| Date | P/E |
| 2024-11-29 | -0.97 |
| 2024-11-28 | -0.88 |
| 2024-11-27 | -0.86 |
| 2024-11-26 | -0.87 |
| 2024-11-25 | -0.89 |
| 2024-11-22 | -0.89 |
| 2024-11-21 | -0.92 |
| 2024-11-20 | -0.97 |
| 2024-11-19 | -0.97 |
| 2024-11-18 | -0.99 |
| 2024-11-15 | -1.01 |
| 2024-11-14 | -1.10 |
| 2024-11-13 | -1.18 |
| 2024-11-12 | -1.15 |
| 2024-11-11 | -1.16 |
| 2024-11-08 | -1.23 |
| 2024-11-07 | -1.25 |
| 2024-11-06 | -1.18 |
| 2024-11-05 | -1.25 |
| 2024-11-04 | -1.24 |
| 2024-11-01 | -1.38 |
| 2024-10-31 | -1.39 |
| 2024-10-30 | -1.45 |
| 2024-10-29 | -1.57 |
| 2024-10-28 | -1.55 |
| 2024-10-25 | -1.61 |
| 2024-10-24 | -1.60 |
| 2024-10-23 | -1.61 |
| 2024-10-22 | -1.60 |
| 2024-10-21 | -1.63 |
| 2024-10-18 | -1.66 |
| 2024-10-17 | -1.66 |
| 2024-10-16 | -1.73 |
| 2024-10-15 | -1.59 |
| 2024-10-14 | -1.63 |
| 2024-10-11 | -1.64 |
| 2024-10-10 | -1.61 |
| 2024-10-09 | -1.69 |
| 2024-10-08 | -1.74 |
| 2024-10-07 | -1.81 |
| 2024-10-04 | -1.69 |
| 2024-10-03 | -1.74 |
| 2024-10-02 | -1.80 |
| 2024-10-01 | -1.78 |
| 2024-09-30 | -1.83 |
| 2024-09-27 | -1.85 |
| 2024-09-26 | -1.75 |
| 2024-09-25 | -1.87 |
| 2024-09-24 | -1.75 |
| 2024-09-23 | -1.93 |